Multi-point Intra-mucosal Injections of Cross-linked Hyaluronic Acid (DESIRIAL®) in the Vaginal Vestibule

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 19, 2017

Primary Completion Date

February 13, 2019

Study Completion Date

February 13, 2019

Conditions
MenopauseDyspareunia
Interventions
DEVICE

DESIRIAL® (Intra-mucosal Injections of Cross-linked Hyaluronic Acid)

"Multi-point Intra-mucosal Injections of Cross-linked Hyaluronic Acid (DESIRIAL®) in the Vaginal Vestibule~The intervention is Intended for intra-mucosal injection in women for biostimulation / rehydration of the surface layers of the lining of the genital areas, vaginal hypotrophies and / or treatment of female sexual dysfunction related to subsidence G spot or area of Gräfenberg .~Following disinfection and topical anesthesia (lidocaine gel), the vesitbule is injected using a multi-point technique. The optimal volume of DESIRIAL® to be used for injection into the vestibule is approximately 0.3 ml in total."

Trial Locations (2)

30029

CHRU de Nîmes - Hôpital Universitaire Carémeau, Nîmes

66000

Centre Médical KARIS, Perpignan

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Laboratoires Vivacy

INDUSTRY

lead

Centre Hospitalier Universitaire de Nīmes

OTHER